HRTX
Heron TherapeuticsยทNASDAQ
--
--(--)
--
--(--)
HRTX Profile
Heron Therapeutics, Inc.
A commercial-stage biotechnology company that develops therapeutics used in nausea and vomiting prevention, pain management, and to treat inflammation
100 Regency Forest Drive, Suite 300, Cary, North Carolina 27518
--
Heron Therapeutics, Inc., was incorporated in California in February 1983 and re-registered in Delaware in 1987. The company is a commercialization stage biotechnology company dedicated to the development and commercialization of innovative therapeutic products for acute care and oncology patients. Its emergency care portfolio includes ZYNRELEF, a double-acting local anesthetic for postoperative pain, and APONVIE, an intravenous preparation for postoperative nausea and vomiting.
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
